Plant Comparison

Common Juniper vs American Cranberry

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant

Second plant

Plant ACommon JuniperJuniperus communisCupressaceaeFull monograph →

Plant BAmerican CranberryVaccinium macrocarponEricaceaeFull monograph →

At a glance

Common Juniper and American Cranberry: they share 3 indicated uses (infection (general), urinary support, urinary tract infection (uti)); 2 pharmacological actions in common.

Common JuniperAmerican Cranberry

Constituents24

Pharmacological actions62

Indicated uses83

Safety notes23

Cited sources2215

Indicated uses

Only Common Juniper

BloatingCancer (anticancer research)IndigestionSwelling / fluid retentionWounds

Shared (3)

Infection (general)Urinary supportUrinary tract infection (UTI)

Only American Cranberry

none

Pharmacological actions

Only Common Juniper

Anticancer (preclinical)AntimicrobialDigestive aidDiuretic

Shared (2)

AntioxidantUrinary antiseptic

Only American Cranberry

none

Evidence face-off — shared uses

Condition	Common Juniper	American Cranberry	Verdict
Infection (general)	1/10	9/10	Stronger for American Cranberry
Urinary support	1/10	8/10	Stronger for American Cranberry
Urinary tract infection (UTI)	1/10	10/10	Stronger for American Cranberry

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Essential oil (alpha-pinene, sabinene, limonene)^[1]

Berry essential oil dominated by alpha-pinene, beta-pinene, sabinene and limonene, giving the characteristic aroma and the antimicrobial activity.

Essential (volatile) oilTerpenes / terpenoids

Flavonoids and tannins

Antioxidant and astringent supporting constituents.

FlavonoidsTannins

A-type proanthocyanidins (PACs)^[11]

The constituents responsible for the anti-adhesion effect against uropathogenic E. coli.

Proanthocyanidins

Flavan-3-ols, anthocyanins and other flavonoids^[11]

Antioxidant polyphenols of the berry.

AnthocyaninsPhenolic compoundsFlavonoids

Phenolic acids and organic acids (quinic, malic, citric)^[11]

Contribute to the acidity and antioxidant capacity.

Phenolic acids

Oxalates^[12]

Present in relatively high amounts; relevant to kidney-stone risk.

Pharmacological Actions

Anticancer (preclinical)^{[3, 12, 13, 14]}

Antimicrobial^{[4, 5, 7, 8, 9, 15, 17, 18, 19]}

Antioxidant^{[4, 6, 10, 11, 17, 18, 19]}

Digestive aid^{[6, 17, 18, 19]}

Diuretic^{[5, 11, 17, 18, 19]}

Urinary antiseptic^{[17, 18, 19]}

Antioxidant^{[8, 11]}

Urinary antiseptic^{[1, 2, 9, 11]}

Anti-adhesion of uropathogenic Escherichia coli to the urinary tract lining

Traditional & Indicated Uses

Bloating^{[17, 18, 19]}Traditional · 1/10

inferred from digestive action

Evidence: 1

Label: Bloating

Cancer (anticancer research)^{[3, 12, 13, 14]}Traditional · 2/10

inferred from anticancer action

Evidence: 2

Label: Cancer (anticancer research)

Indigestion^{[17, 18, 19]}Traditional · 1/10

inferred from digestive action

Evidence: 1

Label: Indigestion

Infection (general)^{[17, 18, 19]}Traditional · 1/10

inferred from antimicrobial action

Evidence: 1

Label: Infection (general)

Swelling / fluid retention^{[17, 18, 19]}Traditional · 1/10

inferred from diuretic action

Evidence: 1

Label: Swelling / fluid retention

Urinary support^{[17, 18, 19]}Traditional · 1/10

inferred from diuretic action

Evidence: 1

Label: Urinary support

Urinary tract infection (UTI)^{[17, 18, 19]}Traditional · 1/10

inferred from diuretic action

Evidence: 1

Label: Urinary tract infection (UTI)

Wounds^{[17, 18, 19]}Traditional · 1/10

inferred from antimicrobial action

Evidence: 1

Label: Wounds

Infection (general)^{[1, 5, 10, 11, 12, 13]}Strong · 9/10

Prevention of recurrent urinary tract infections (UTI), especially in women

Evidence: 9

Label: Infection (general)

Urinary support^{[3, 7, 11]}Good · 8/10

inferred from urinary-antiseptic action

Evidence: 8

Label: Urinary support

Urinary tract infection (UTI)^{[1, 2, 3, 4, 5, 6, 7, 9, 10, 11, 12, 13]}Strong · 10/10

Anti-adhesion of uropathogenic Escherichia coli to the urinary tract lining; Prevention of recurrent urinary tract infections (UTI), especially in women

Evidence: 10

Label: Urinary tract infection (UTI)

Safety, Cautions & Contraindications

Safety note^{[17, 18, 19]}Caution

Avoid in pregnancy. Juniper is not recommended during pregnancy (EMA/HMPC, 2023; Health Canada, 2025).Avoid with kidney disorders / serious kidney disease. It’s not recommended if you have kidney disease (EMA/HMPC, 2023; Health Canada, 2025).Adults only (for medicinal use). Use in under-18s is not recommended due to lack of data (EMA/HMPC, 2023).Hydration matters. If you’re using it for urinary “flushing,” you need adequate fluid intake (EMA/HMPC, 2023).Stop and seek help if symptoms look serious. Fever, painful urination, cramps/spasms, or blood in urine = talk to a clinician (EMA/HMPC, 2023).Duration caution. If using it beyond a few weeks, talk to a health professional (Health Canada, 2025).If breastfeeding: ask a health professional first (EMA/HMPC, 2023; Health Canada, 2025).

Safety note^{[17, 18, 19, 20]}Caution

Duke (2002) rates juniper as + (use with caution), noting diuretic, carminative, and aquaretic activities, primarily at the experimental level (score 1). Traditional use for urinary infections is not supported by strong clinical evidence. The essential oil contains potentially nephrotoxic terpinen-4-ol, and juniper is contraindicated in kidney disease, urinary infections with inflammation, and pregnancy (emmenagogue and potential abortifacient properties). Commission E and PhEur do not recommend medicinal doses for prolonged use exceeding 4–6 weeks (Duke, 2002).

Safety note^{[12, 13]}Info

Best supported for PREVENTION of recurrent UTIs, not for treating an active infection; an established UTI needs proper medical assessment and, usually, antibiotics.

Safety note^[12]Caution

May interact with the anticoagulant warfarin (evidence is conflicting); people taking warfarin should be cautious and consult their clinician.

Safety note^[12]Caution

High in oxalates; people with a history of kidney stones should avoid large or prolonged intake. Many cranberry juices are also high in sugar.

External Ids

Gbif: 2684709

Wikidata: Q26325

Gbif: 2882841

Wikidata: Q149397

Botanical Description

Evergreen coniferous shrub or small tree, often low and sprawling, with sharp, needle-like leaves in whorls of three, each bearing a single white band on the upper surface. The plant is dioecious; female plants bear small, round, fleshy, berry-like cones ('juniper berries') that take two to three years to ripen from green to blue-black.^[1]

Height: 1-10 m, highly variable (often a low sprawling shrub)

Habit: Evergreen coniferous shrub or small tree, often sprawling

Leaves: Sharp, needle-like, in whorls of three, each with a single white band above

Flowers: Dioecious, wind-pollinated, inconspicuous

Stem: Woody, often sprawling or low-growing, reddish-brown bark

Root: Woody, spreading root system

Fruit: Round, fleshy, berry-like cone, ripening blue-black over two to three years

Flowering Period: Spring

Low, trailing, evergreen woody vine with small, wiry stems and small, oval, leathery leaves. Small, pink, four-petalled flowers with reflexed petals give way to round to oblong, tart red berries.

Height: 5-20 cm (trailing vine, stems can spread 1-2 m)

Habit: Low, trailing, evergreen woody vine

Leaves: Small, oval, leathery, dark green above and pale beneath

Flowers: Small, pink, four-petalled with reflexed (swept-back) petals

Stem: Wiry, trailing, rooting at nodes

Root: Shallow, fibrous root system

Fruit: Round to oblong, tart, red berry

Flowering Period: May-July

Habitat

Grows on heath, moorland, rocky hillsides and open coniferous woodland on poor, often calcareous soils; one of the most widely distributed conifers, native across the Northern Hemisphere from Europe and Asia to North America.

Grows in acidic bogs, wetlands and sandy peat soils; native to North America and now widely cultivated commercially, especially in flooded bogs.

Harvesting

The ripe, blue-black berry-like cones are hand-picked in autumn, typically in their second or third year of ripening (a mix of ages is often present on the same shrub); leaves and young stems can be gathered through the growing season.

Parts: Fruit, Leaf, Stem

Season: Fruit in autumn, when fully ripe (blue-black)

Berries are harvested in autumn when fully red, either dry-picked or by flooding the bog so the berries float (wet harvest) for collection.

Parts: Fruit (berry)

Season: Autumn

Traditional Uses

Juniper berry has a long European tradition as a diuretic and urinary antiseptic for minor urinary complaints, a warming digestive carminative for indigestion and bloating, and a flavouring for gin and other spirits; the leaf and wood have also been burned or used topically for their antimicrobial properties.^[1]

Cranberry has a long Native American and North American folk tradition as a food and remedy for urinary complaints, an association now well supported by modern research showing its A-type proanthocyanidins prevent E. coli from adhering to the urinary tract lining, making it most useful for prevention of recurrent UTIs rather than treatment of an active infection.^[13]

Preparations

Infusion (berries)^[16]

Comminuted juniper cone berries infused in 150 ml boiling water, 2.0-2.5 g as a single dose 1-3 times daily per the current revision of the EU herbal monograph. Educational reference only, not a prescription.

Essential oil^[1]

Steam-distilled from the berries; used in small internal doses for short periods or diluted for topical/aromatic use.

Juice^[13]

Unsweetened or lightly sweetened cranberry juice, taken regularly as a traditional and modern preventive measure for recurrent UTIs.

Standardized tablet/capsule^[13]

Standardized proanthocyanidin (PAC) extract in tablet or capsule form, used for UTI prevention in clinical research.

Dosage

Berry infusion^{[16, 17]}

The EU herbal monograph gives 2.0-2.5 g of the comminuted cone berries in 150 mL of boiling water as an infusion, 1-3 times daily (single dose 2-2.5 g, daily dose 2.5-6 g), for adults and elderly. Use is limited to short courses - if symptoms persist beyond 2 weeks a healthcare practitioner should be consulted - with adequate fluid intake; contraindicated in severe renal disease and not recommended in pregnancy. Educational reference only, not a prescription.

Juice/extract^[13]

Clinical research commonly uses around 36 mg PAC daily (standardized extract) or 240-300 mL unsweetened juice daily for UTI prevention. Educational reference only, not a prescription.

References

REF-0851, REF-0852, REF-0853, REF-1734, REF-1735, REF-1736, REF-1737, REF-1738, REF-1739, REF-1740, REF-1741, REF-1742, REF-1743, REF-1744, REF-1745

REF-1338, REF-1339, REF-1340, REF-1341, REF-1342, REF-1343, REF-1344, REF-1345, REF-1346, REF-1347

Lookalikes Review

Outcome: has-lookalikes

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Outcome: none-known

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Dangerous Lookalikes

Safety note^{[21, 22]}Dangerous

Dangerous Plant: juniperus-sabina

Confused Part: Berry-like cones ('juniper berries') and foliage harvested for flavouring or tea; the toxic ornamental savin juniper is easily taken for edible common juniper, especially in gardens and parks.

Confusion Context: Common juniper (Juniperus communis) berries flavour food and gin, but not all junipers are edible. Savin juniper (Juniperus sabina) is a low, spreading ornamental juniper that is genuinely poisonous: a peer-reviewed analysis (Zheljazkov et al., 2021) found the antimitotic cell poison podophyllotoxin in savin but NOT in common juniper, and savin also contains irritant terpenes (sabinene, sabinol) and has long been a dangerous abortifacient. Because savin is widely planted in yards, parks and landscaping, 'juniper berries' picked from cultivated shrubs can be this toxic species; foraging guidance stresses positively identifying the species before eating any juniper.

Distinguishing Features: Foliage (decisive): edible common juniper has sharp-pointed NEEDLE-like leaves in whorls of three, each with a single white band on the upper surface. Savin and most ornamental junipers have soft, SCALE-like leaves pressed against the twig. Whorls of three sharp needles = common juniper; scale-like foliage = a juniper to avoid., Smell: savin foliage has an acrid, unpleasant (foetid) smell when crushed, unlike the clean gin-like aroma of common juniper., Habit: common juniper is a bushy shrub or small tree of wild heath and hillside; savin is a low, wide-spreading ornamental grown in gardens and municipal planting.

Key Test: Check the leaves. Sharp needle-like leaves in whorls of three (with a white band on top) = common juniper, the edible one. Soft scale-like foliage hugging the twig - especially on a low spreading shrub in a garden or park - with an acrid smell when crushed = a juniper to avoid such as savin (Juniperus sabina), which is toxic. Never eat juniper berries unless you have confirmed the species is common juniper.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-07

Not documented

Drug Class Interactions

Not documented

Safety note^{[14, 15]}Caution

Drug Class: anticoagulants-antiplatelets

Mechanism: Regularly drinking large amounts of cranberry juice has been linked to raised INR and bleeding in people taking warfarin, and UK drug-safety authorities advise caution; occasional small amounts are unlikely to matter. If you take a blood thinner, keep cranberry intake modest and steady and tell your clinician.

Reviewed By: Omnia Sana (owner-authorized)

Reviewed Date: 2026-07-03

References & Sources

Pepeljnjak, S., Kosalec, I., Kalodera, Z. and Blazević, N (2005) 'Antimicrobial activity of juniper berry essential oil (Juniperus communis L., Cupressaceae)', Acta Pharmaceutica, 55(4), pp. 417-422. Available at: https://pubmed.ncbi.nlm.nih.gov/16375831/ Preclinical
https://pubmed.ncbi.nlm.nih.gov/16375831/
Peruč, D., Tićac, B., Broznić, D., Maglica, Ž. et al (2020) 'Juniperus communis essential oil limits the biofilm formation of Mycobacterium avium and Mycobacterium intracellulare on polystyrene in a temperature-dependent manner', International Journal of Environmental Health Research, 32(1), pp. 141-154. doi:10.1080/09603123.2020.1741519 Preclinical
https://doi.org/10.1080/09603123.2020.1741519
Marković, T., Popović, S., Matić, S., Mitrović, M. et al (2024) 'Insights into Molecular Mechanisms of Anticancer Activity of Juniperus communis Essential Oil in HeLa and HCT 116 Cells', Plants (Basel), 13(17), pp. 2351. doi:10.3390/plants13172351 Preclinical
https://doi.org/10.3390/plants13172351
Goncalves, A.C., Flores-Felix, J.D., Coutinho, P., Alves, G. and Silva, L.R (2022) 'Zimbro (Juniperus communis L.) as a Promising Source of Bioactive Compounds and Biomedical Activities: A Review on Recent Trends', International Journal of Molecular Sciences, 23(6), pp. 3197. doi:10.3390/ijms23063197 Meta-analysis / review
https://doi.org/10.3390/ijms23063197
Bais, S., Gill, N.S., Rana, N. and Shandil, S (2014) 'A Phytopharmacological Review on a Medicinal Plant: Juniperus communis', International Scholarly Research Notices, 2014, pp. 634723. doi:10.1155/2014/634723 Meta-analysis / review
https://doi.org/10.1155/2014/634723
Raina, R., Verma, P.K., Peshin, R. and Kour, H (2019) 'Potential of Juniperus communis L as a nutraceutical in human and veterinary medicine', Heliyon, 5(8), pp. e02376. doi:10.1016/j.heliyon.2019.e02376 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2019.e02376
Gordien, A.Y., Gray, A.I., Franzblau, S.G. and Seidel, V (2009) 'Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae)', Journal of Ethnopharmacology, 126(3), pp. 500-505. doi:10.1016/j.jep.2009.09.007 Preclinical
https://doi.org/10.1016/j.jep.2009.09.007
Klancnik, A., Zorko, S., Toplak, N., Kovac, M., Bucar, F., Jersek, B. and Smole Mozina, S (2017) 'Antiadhesion activity of juniper (Juniperus communis L.) preparations against Campylobacter jejuni evaluated with PCR-based methods', Phytotherapy Research, 32(3), pp. 542-550. doi:10.1002/ptr.6005 Preclinical
https://doi.org/10.1002/ptr.6005
Maurya, A.K., Devi, R., Kumar, A., Koundal, R., Thakur, S., Sharma, A., Kumar, D., Kumar, R., Padwad, Y.S., Chand, G., Singh, B. and Agnihotri, V.K (2018) 'Chemical Composition, Cytotoxic and Antibacterial Activities of Essential Oils of Cultivated Clones of Juniperus communis and Wild Juniperus Species', Chemistry & Biodiversity, 15(9), pp. e1800183. doi:10.1002/cbdv.201800183 Preclinical
https://doi.org/10.1002/cbdv.201800183
Jegal, J., Park, S., Chung, K., Chung, H.Y., Lee, J., Jeong, E.J., Kim, K.H. and Yang, M.H (2016) 'Tyrosinase inhibitory flavonoid from Juniperus communis fruits', Bioscience, Biotechnology, and Biochemistry, 80(12), pp. 2311-2317. doi:10.1080/09168451.2016.1217146 Preclinical
https://doi.org/10.1080/09168451.2016.1217146
Lin, T., Lu, C., Chang, K. and Lee, C (2022) 'Juniperus communis extract ameliorates lipopolysaccharide-induced acute kidney injury through the adenosine monophosphate-activated protein kinase pathway', Food Science & Nutrition, 10(10), pp. 3405-3414. doi:10.1002/fsn3.2941 Preclinical
https://doi.org/10.1002/fsn3.2941
Gao, H., Huang, X., Yang, T., Chang, K., Yeh, L., Hsieh, M., Weng, J. and Tsai, N (2019) 'Juniperus communis Suppresses Melanoma Tumorigenesis by Inhibiting Tumor Growth and Inducing Apoptosis', The American Journal of Chinese Medicine, 47(5), pp. 1171-1191. doi:10.1142/S0192415X19500605 Preclinical
https://doi.org/10.1142/S0192415X19500605
Huang, N., Huang, R., Huang, X., Chang, K., Lee, C., Hsiao, C., Lee, S. and Tsai, N (2021) 'Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo', Bioscience Reports, 41(7), pp. BSR20211143. doi:10.1042/BSR20211143 Preclinical
https://doi.org/10.1042/BSR20211143
Lai, W., Lee, S., Chang, K., Huang, X., Li, C., Lee, C., Wu, C., Hsu, H. and Tsai, N (2021) 'Juniperus communis extract induces cell cycle arrest and apoptosis of colorectal adenocarcinoma in vitro and in vivo', Brazilian Journal of Medical and Biological Research, 54(10), pp. e10891. doi:10.1590/1414-431X2020e10891 Preclinical
https://doi.org/10.1590/1414-431X2020e10891
Peruc, D., Ticac, B., Abram, M., Broznic, D., Stifter, S., Staver, M.M. and Gobin, I (2019) 'Synergistic potential of Juniperus communis and Helichrysum italicum essential oils against nontuberculous mycobacteria', Journal of Medical Microbiology, 68(5), pp. 703-710. doi:10.1099/jmm.0.000962 Preclinical
https://doi.org/10.1099/jmm.0.000962
European Medicines Agency (HMPC) (2023) 'European Union herbal monograph on Juniperus communis L., galbulus (pseudo-fructus), Revision 1'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-juniperus-communis-l-pseudo-fructus-galbulus-revision-1_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-juniperus-communis-l-pseudo-fructus-galbulus-revision-1_en.pdf
European Medicines Agency (2010) 'European Union herbal monograph on Juniperus communis L., pseudo-fructus'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Juniperus%20communis%20L.%2C%20pseudo-fructus
British Herbal Medicine Association (1983) 'British Herbal Pharmacopoeia'. Traditional / reference
https://scholar.google.com/scholar?q=British%20Herbal%20Pharmacopoeia
Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org
Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Four Season Foraging (2025) 'Is Juniper Toxic?'. Available at: https://www.fourseasonforaging.com/blog/2025/4/17/is-juniper-toxic Traditional / reference
https://www.fourseasonforaging.com/blog/2025/4/17/is-juniper-toxic
Zheljazkov, V.D. and Cantrell, C.L. and Semerdjieva, I. and Radoukova, T. and Stoyanova, A. and Maneva, V. and Kacaniova, M. and Astatkie, T. and Borisova, D. and Dincheva, I. and Salamon, I (2021) 'Essential Oil Composition and Bioactivity of Two Juniper Species from Bulgaria and Slovakia', Molecules, 26(12), pp. 3659. doi:10.3390/molecules26123659 Preclinical
https://doi.org/10.3390/molecules26123659

Williams, G., Hahn, D., Stephens, J.H., Craig, J.C. and others (2023) 'Cranberries for preventing urinary tract infections', Cochrane Database of Systematic Reviews, 4(4), pp. CD001321. doi:10.1002/14651858.CD001321.pub6 Meta-analysis / review
https://doi.org/10.1002/14651858.CD001321.pub6
Mantzorou, M. and Giaginis, C (2018) 'Cranberry Consumption Against Urinary Tract Infections: Clinical State-of-the-Art and Future Perspectives', Current Pharmaceutical Biotechnology, 19(13), pp. 1049-1063. doi:10.2174/1389201020666181206104129 Meta-analysis / review
https://doi.org/10.2174/1389201020666181206104129
Fu, Z., Liska, D., Talan, D. and Chung, M (2017) 'Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women: A Systematic Review and Meta-Analysis', The Journal of Nutrition, 147(12), pp. 2282-2288. doi:10.3945/jn.117.254961 Meta-analysis / review
https://doi.org/10.3945/jn.117.254961
Xia, J.Y., Yang, C., Xu, D.F., Xia, H. and others (2021) 'Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis', PLoS One, 16(9), pp. e0256992. doi:10.1371/journal.pone.0256992 Meta-analysis / review
https://doi.org/10.1371/journal.pone.0256992
Maki, K.C., Kaspar, K.L., Khoo, C., Derrig, L.H. and others (2016) 'Consumption of a cranberry juice beverage lowered the number of clinical urinary tract infection episodes in women with a recent history of urinary tract infection', The American Journal of Clinical Nutrition, 103(6), pp. 1434-1442. doi:10.3945/ajcn.116.130542 Randomized trial
https://doi.org/10.3945/ajcn.116.130542
Babar, A., Moore, L., Leblanc, V., Dudonne, S. and others (2021) 'High dose versus low dose standardized cranberry proanthocyanidin extract for the prevention of recurrent urinary tract infection in healthy women: a double-blind randomized controlled trial', BMC Urology, 21(1), pp. 44. doi:10.1186/s12894-021-00811-w Randomized trial
https://doi.org/10.1186/s12894-021-00811-w
Perez-Lopez, F.R., Haya, J. and Chedraui, P (2009) 'Vaccinium macrocarpon: an interesting option for women with recurrent urinary tract infections and other health benefits', Journal of Obstetrics and Gynaecology Research, 35(4), pp. 630-639. doi:10.1111/j.1447-0756.2009.01026.x Meta-analysis / review
https://doi.org/10.1111/j.1447-0756.2009.01026.x
Nemzer, B.V., Al-Taher, F., Yashin, A., Revelsky, I. and others (2022) 'Cranberry: Chemical Composition, Antioxidant Activity and Impact on Human Health: Overview', Molecules, 27(5), pp. 1503. doi:10.3390/molecules27051503 Meta-analysis / review
https://doi.org/10.3390/molecules27051503
Davidson, E., Zimmermann, B.F., Jungfer, E. and Chrubasik-Hausmann, S (2014) 'Prevention of urinary tract infections with Vaccinium products', Phytotherapy Research, 28(3), pp. 465-470. doi:10.1002/ptr.5047 Meta-analysis / review
https://doi.org/10.1002/ptr.5047
Tsiakoulias, E., Gravas, S., Hadjichristodoulou, C., Oikonomou, K.G. and others (2024) 'Randomized, placebo-controlled, double-blinded study of prophylactic cranberries use in women with recurrent uncomplicated cystitis', World Journal of Urology, 42(1), pp. 27. doi:10.1007/s00345-023-04741-0 Randomized trial
https://doi.org/10.1007/s00345-023-04741-0
Gonzalez de Llano, D., Moreno-Arribas, M.V. and Bartolome, B (2020) 'Cranberry Polyphenols and Prevention against Urinary Tract Infections: Relevant Considerations', Molecules. doi:10.3390/molecules25153523 Traditional / reference
https://doi.org/10.3390/molecules25153523
National Center for Complementary and Integrative Health (NCCIH) (2020) 'Cranberry: Usefulness and Safety'. Available at: https://www.nccih.nih.gov/health/cranberry Traditional / reference
https://www.nccih.nih.gov/health/cranberry
Moro, C., Phelps, C., Veer, V., Jones, M., Glasziou, P., Clark, J., Tikkinen, K.A.O. and Scott, A.M (2024) 'Cranberry Juice, Cranberry Tablets, or Liquid Therapies for Urinary Tract Infection: A Systematic Review and Network Meta-analysis', European Urology Focus. doi:10.1016/j.euf.2024.07.002 Meta-analysis / review
https://doi.org/10.1016/j.euf.2024.07.002
Aston, J.L., Lodolce, A.E. and Shapiro, N.L (2006) 'Interaction between warfarin and cranberry juice', Pharmacotherapy, 26(9), pp. 1314-1319. doi:10.1592/phco.26.9.1314 Meta-analysis / review
https://doi.org/10.1592/phco.26.9.1314
Paeng, C.H., Sprague, M. and Jackevicius, C.A (2007) 'Interaction between warfarin and cranberry juice', Clinical Therapeutics, 29(8), pp. 1730-1735. doi:10.1016/j.clinthera.2007.08.018 Clinical study
https://doi.org/10.1016/j.clinthera.2007.08.018

Common Juniper monograph American Cranberry monograph Compare other plants

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.